Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype.

Sciurba FC, Criner GJ, Christenson SA, Martinez FJ, Papi A, Roche N, Bourbeau J, Korn S, Bafadhel M, Han MK, Kolterer S, Miller K, Mouneimne D, Fletcher J, Mayer B, Min J, Pavord ID, MATINEE Study Investigators

Open source

DOI: 10.1056/nejmoa2413181
Published: 2025 May 1
Container: The New England journal of medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2413181,
  title = {Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype.},
  author = {Sciurba FC and Criner GJ and Christenson SA and Martinez FJ and Papi A and Roche N and Bourbeau J and Korn S and Bafadhel M and Han MK and Kolterer S and Miller K and Mouneimne D and Fletcher J and Mayer B and Min J and Pavord ID and MATINEE Study Investigators},
  year = {2025},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa2413181},
  url = {https://doi.org/10.1056/nejmoa2413181}
}

RIS

TY  - JOUR
TI  - Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype.
AU  - Sciurba FC
AU  - Criner GJ
AU  - Christenson SA
AU  - Martinez FJ
AU  - Papi A
AU  - Roche N
AU  - Bourbeau J
AU  - Korn S
AU  - Bafadhel M
AU  - Han MK
AU  - Kolterer S
AU  - Miller K
AU  - Mouneimne D
AU  - Fletcher J
AU  - Mayer B
AU  - Min J
AU  - Pavord ID
AU  - MATINEE Study Investigators
PY  - 2025
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa2413181
UR  - https://doi.org/10.1056/nejmoa2413181
ER  -

APA

FC, S., GJ, C., SA, C., FJ, M., A, P., N, R., J, B., S, K., M, B., MK, H., S, K., K, M., D, M., J, F., B, M., J, M., ID, P., & Investigators, M. S. (2025). Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype.. The New England journal of medicine. https://doi.org/10.1056/nejmoa2413181

Source records

pubmed · retrieved 2026-09-25T15:40:59.119Z